---
figid: PMC6513850__41598_2019_43820_Fig8_HTML
figlink: /pmc/articles/PMC6513850/figure/Fig8/
number: Figure 8
caption: Diagrammatic model summarising the proposed bimodal Wnt signalling regulation
  by DYRK1A, as reported in Figs –. (A) Basal/Inactive Wnt signalling conditions,
  whereby nuclear translocation of β-catenin is prevented via its proteasomal degradation,
  mediated by the destruction complex. (B) Active Wnt signalling, whereby Frizzled
  receptor stimulation by ligands results in membrane recruitment of the destruction
  complex, cytosolic release and nuclear translocation of ‘free’ β-catenin followed
  by TCF/LEF binding and transcriptional activation of Wnt target genes. (C) DYRK1A
  overexpression alone results in significant downregulation of Wnt signalling activity
  (Fig. , blue) along with prominent nuclear localisation of the DYRK1A protein (Fig. ,
  left green). (D) DYRK1A-DVL1 co-expression (ie under active Wnt signalling conditions)
  significantly enhances Wnt signalling activation levels (Fig. , red) and leads to
  cytoplasmic accumulation of DYRK1A (Fig. , right green), likely mediated by direct
  interaction with DVL1 (Figs  and , right yellow). This DYRK1A redistribution pattern
  is also observed following Wnt stimulation with LiCl or Wnt3a (Fig. , right green).
  (E) Consistently, DYRK1A inhibition results in decreased levels of active Wnt signalling
  following LiCl or Wnt3a treatment, relative to pathway stimulation alone (Fig. ).
  APC - Adenomatous polyposis coli; β-cat - β-catenin; DKK - Dickkopf-related protein;
  DVL - Disheveled 1; GSK-3β - Glycogen synthase kinase 3β; KRM - Kremen co-receptor;
  LRP5/6 - Low-density lipoprotein receptor-related protein 5/6; P - Phosphorylation;
  TCF/LEF - T-cell factor/lymphoid enhancer factor.
pmcid: PMC6513850
papertitle: Downregulated Wnt/β-catenin signalling in the Down syndrome hippocampus.
reftext: Simone Granno, et al. Sci Rep. 2019;9:7322.
pmc_ranked_result_index: '28464'
pathway_score: 0.9695127
filename: 41598_2019_43820_Fig8_HTML.jpg
figtitle: Diagrammatic model summarising the proposed bimodal Wnt signalling regulation
  by DYRK1A, as reported in Figs –
year: '2019'
organisms: Homo sapiens
ndex: 86b3b14b-dec8-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6513850__41598_2019_43820_Fig8_HTML.html
  '@type': Dataset
  description: Diagrammatic model summarising the proposed bimodal Wnt signalling
    regulation by DYRK1A, as reported in Figs –. (A) Basal/Inactive Wnt signalling
    conditions, whereby nuclear translocation of β-catenin is prevented via its proteasomal
    degradation, mediated by the destruction complex. (B) Active Wnt signalling, whereby
    Frizzled receptor stimulation by ligands results in membrane recruitment of the
    destruction complex, cytosolic release and nuclear translocation of ‘free’ β-catenin
    followed by TCF/LEF binding and transcriptional activation of Wnt target genes.
    (C) DYRK1A overexpression alone results in significant downregulation of Wnt signalling
    activity (Fig. , blue) along with prominent nuclear localisation of the DYRK1A
    protein (Fig. , left green). (D) DYRK1A-DVL1 co-expression (ie under active Wnt
    signalling conditions) significantly enhances Wnt signalling activation levels
    (Fig. , red) and leads to cytoplasmic accumulation of DYRK1A (Fig. , right green),
    likely mediated by direct interaction with DVL1 (Figs  and , right yellow). This
    DYRK1A redistribution pattern is also observed following Wnt stimulation with
    LiCl or Wnt3a (Fig. , right green). (E) Consistently, DYRK1A inhibition results
    in decreased levels of active Wnt signalling following LiCl or Wnt3a treatment,
    relative to pathway stimulation alone (Fig. ). APC - Adenomatous polyposis coli;
    β-cat - β-catenin; DKK - Dickkopf-related protein; DVL - Disheveled 1; GSK-3β
    - Glycogen synthase kinase 3β; KRM - Kremen co-receptor; LRP5/6 - Low-density
    lipoprotein receptor-related protein 5/6; P - Phosphorylation; TCF/LEF - T-cell
    factor/lymphoid enhancer factor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - WNT4
  - WNT3A
  - WNT16
  - DVL1
  - DVL3
  - DYRK1A
  - SLC13A5
  - WNT8B
  - WNT10B
  - WNT1
  - WNT2
  - WNT3
  - WNT5A
  - APC
  - AXIN1
  - WNT7A
  - AXIN2
  - CAT
  - DVL2
  - WNT2B
  - WNT7B
  - WNT8A
  - WNT11
  - WNT5B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT6
genes:
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT4
  entrez: '54361'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3A
  entrez: '89780'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT16
  entrez: '51384'
- word: DVL
  symbol: DVL
  source: bioentities_symbol
  hgnc_symbol: DVL1
  entrez: '1855'
- word: DVL
  symbol: DVL
  source: bioentities_symbol
  hgnc_symbol: DVL3
  entrez: '1857'
- word: DYRK1A
  symbol: DYRK1A
  source: hgnc_symbol
  hgnc_symbol: DYRK1A
  entrez: '1859'
- word: INDY
  symbol: INDY
  source: hgnc_alias_symbol
  hgnc_symbol: SLC13A5
  entrez: '284111'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8B
  entrez: '7479'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10B
  entrez: '7480'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT1
  entrez: '7471'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2
  entrez: '7472'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3
  entrez: '7473'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5A
  entrez: '7474'
- word: APC
  symbol: APC
  source: hgnc_symbol
  hgnc_symbol: APC
  entrez: '324'
- word: AXIN
  symbol: AXIN
  source: bioentities_symbol
  hgnc_symbol: AXIN1
  entrez: '8312'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7A
  entrez: '7476'
- word: AXIN
  symbol: AXIN
  source: bioentities_symbol
  hgnc_symbol: AXIN2
  entrez: '8313'
- word: CAT
  symbol: CAT
  source: hgnc_symbol
  hgnc_symbol: CAT
  entrez: '847'
- word: DVL
  symbol: DVL
  source: bioentities_symbol
  hgnc_symbol: DVL2
  entrez: '1856'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2B
  entrez: '7482'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7B
  entrez: '7477'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8A
  entrez: '7478'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT11
  entrez: '7481'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5B
  entrez: '81029'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9A
  entrez: '7483'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9B
  entrez: '7484'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10A
  entrez: '80326'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT6
  entrez: '7475'
chemicals: []
diseases: []
---
